系统性硬化症患者的益生菌干预:系统性审查和未来前景
Zahra Mirfeizi1, Mahmoud Mahmoudi2,3, Marzieh Monemi4
1Rheumatology Department, Rheumatic Diseases Research Center Mashhad University of Medical Sciences Mashhad Iran.
Health science reports
|April 17, 2025
概括
益生菌在治疗胃肠道问题和系统性硬化症 (SSc) 患者的免疫反应方面显示出潜力. 需要进一步的研究来确认它们在这种自身免疫性疾病中的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 类风湿病学 类风湿病学
背景情况:
- 系统性硬化症 (SSc) 是一种罕见的自身免疫性疾病,其特点是纤维化和血管问题.
- 胃肠道问题是系统性硬化症患者的常见并发症.
- 需要新的治疗策略来管理SSc并发症并改善患者的治疗结果.
研究的目的:
- 探索益生菌在治疗系统性硬化症中胃肠道症状方面的潜在治疗作用.
- 在系统性硬化症的背景下研究益生菌的免疫调节作用.
- 审查目前有关SSc患者益生菌干预措施的证据.
主要方法:
- 进行了广泛的文献搜索,截至2023年10月.
- 搜索的数据库包括科学网,PubMed/MEDLINE和Scopus.
- 该审查包括非随机观察性研究和随机临床试验.
主要成果:
- 确定了四篇文章,调查了益生菌对系统性硬化症的影响.
- 初步发现表明,益生菌可能调节SSc.中的免疫反应.
- 有证据表明,益生菌在改善SSc患者的胃肠道症状方面具有潜在的有效性.
结论:
- 益生菌可能提供一种有益的方法来管理胃肠道症状和系统性硬化症的免疫反应.
- 目前的证据基础有限,需要进一步调查.
- 需要严格的随机对照试验来验证益生菌在SSc中的有效性.
相关概念视频
Chronic Bowel Disorders: Introduction
908
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
908
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
780
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
780
Inflammatory Bowel Disease IV: Pharmacological Management
1.1K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
1.1K
Probiotics
300
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
300
Inflammatory Bowel Disease I: Introduction
79
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
79
Inflammatory Bowel Disease IV: Clinical Manifestations
64
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
64


